| ALK-negative anaplastic large cell lymphoma is a genetically heterogeneous disease with widely disparate clinical outcomes ER Parrilla Castellar, ES Jaffe, JW Said, SH Swerdlow, RP Ketterling, ... Blood, The Journal of the American Society of Hematology 124 (9), 1473-1480, 2014 | 504 | 2014 |
| Lenalidomide combined with R-CHOP overcomes negative prognostic impact of non-germinal center B-cell phenotype in newly diagnosed diffuse large B-Cell lymphoma: a phase II study GS Nowakowski, B LaPlant, WR Macon, CB Reeder, JM Foran, ... J Clin Oncol 33 (3), 251-257, 2015 | 417 | 2015 |
| Subcutaneous panniculitis-like T-cell lymphoma: clinicopathologic, immunophenotypic, and genotypic analysis of alpha/beta and gamma/delta subtypes KE Salhany, WR Macon, JK Choi, R Elenitsas, SR Lessin, RE Felgar, ... The American journal of surgical pathology 22 (7), 881-893, 1998 | 414 | 1998 |
| Event-free survival at 24 months is a robust end point for disease-related outcome in diffuse large B-cell lymphoma treated with immunochemotherapy MJ Maurer, H Ghesquières, JP Jais, TE Witzig, C Haioun, CA Thompson, ... Journal of Clinical Oncology 32 (10), 1066-1073, 2014 | 401 | 2014 |
| Higher response to lenalidomide in relapsed/refractory diffuse large B‐cell lymphoma in nongerminal center B‐cell–like than in germinal center B‐cell–like phenotype FJ Hernandez‐Ilizaliturri, G Deeb, PL Zinzani, SA Pileri, F Malik, ... Cancer 117 (22), 5058-5066, 2011 | 383 | 2011 |
| Prognostic significance of Bcl-6 protein expression in DLBCL treated with CHOP or R-CHOP: a prospective correlative study JN Winter, EA Weller, SJ Horning, M Krajewska, D Variakojis, ... Blood 107 (11), 4207-4213, 2006 | 366 | 2006 |
| Rates and outcomes of follicular lymphoma transformation in the immunochemotherapy era: a report from the University of Iowa/Mayo Clinic Specialized Program of Research … BK Link, MJ Maurer, GS Nowakowski, SM Ansell, WR Macon, SI Syrbu, ... Journal of clinical oncology 31 (26), 3272, 2013 | 338 | 2013 |
| Epstein-Barr virus–positive lymphoma in patients with inflammatory bowel disease treated with azathioprine or 6-mercaptopurine GA Dayharsh, EV Loftus Jr, WJ Sandborn, WJ Tremaine, AR Zinsmeister, ... Gastroenterology 122 (1), 72-77, 2002 | 320 | 2002 |
| Non‐H odgkin lymphoma subtype distribution, geodemographic patterns, and survival in the US: A longitudinal analysis of the N ational C ancer D ata B ase from 1998 to 2011 M Al‐Hamadani, TM Habermann, JR Cerhan, WR Macon, MJ Maurer, ... American journal of hematology 90 (9), 790-795, 2015 | 301 | 2015 |
| Vitamin D insufficiency and prognosis in non-Hodgkin's lymphoma MT Drake, MJ Maurer, BK Link, TM Habermann, SM Ansell, IN Micallef, ... Journal of clinical oncology 28 (27), 4191, 2010 | 271 | 2010 |
| Diffuse large B‐cell lymphoma (R ichter syndrome) in patients with chronic lymphocytic leukaemia (CLL): a cohort study of newly diagnosed patients SA Parikh, KG Rabe, TG Call, CS Zent, TM Habermann, W Ding, JF Leis, ... British journal of haematology 162 (6), 774-782, 2013 | 250 | 2013 |
| Hepatosplenic αβ T-cell lymphomas: a report of 14 cases and comparison with hepatosplenic γδ T-cell lymphomas WR Macon, NB Levy, PJ Kurtin, KE Salhany, MY Elkhalifa, TT Casey, ... The American journal of surgical pathology 25 (3), 285-296, 2001 | 242 | 2001 |
| High-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements with diffuse large B-cell lymphoma morphology DW Scott, RL King, AM Staiger, S Ben-Neriah, A Jiang, H Horn, A Mottok, ... Blood, The Journal of the American Society of Hematology 131 (18), 2060-2064, 2018 | 228 | 2018 |
| Recurrent translocations involving the IRF4 oncogene locus in peripheral T-cell lymphomas AL Feldman, M Law, ED Remstein, WR Macon, LA Erickson, KL Grogg, ... Leukemia 23 (3), 574-580, 2009 | 223 | 2009 |
| Early event status informs subsequent outcome in newly diagnosed follicular lymphoma MJ Maurer, E Bachy, H Ghesquières, SM Ansell, GS Nowakowski, ... American journal of hematology 91 (11), 1096-1101, 2016 | 222 | 2016 |
| Prognostic analysis for survival in adult solid organ transplant recipients with post-transplantation lymphoproliferative disorders IM Ghobrial, TM Habermann, MJ Maurer, SM Geyer, KM Ristow, ... J Clin Oncol 23 (30), 7574-7582, 2005 | 217 | 2005 |
| Genetic variation in 1253 immune and inflammation genes and risk of non-Hodgkin lymphoma JR Cerhan, SM Ansell, ZS Fredericksen, NE Kay, M Liebow, TG Call, ... Blood, The Journal of the American Society of Hematology 110 (13), 4455-4463, 2007 | 212 | 2007 |
| Natural killer-like T-cell lymphomas: aggressive lymphomas of T-large granular lymphocytes WR Macon, ME Williams, JP Greer, RD Hammer, AD Glick, RD Collins, ... Blood 87 (4), 1474-1483, 1996 | 209 | 1996 |
| Seroma-associated primary anaplastic large-cell lymphoma adjacent to breast implants: an indolent T-cell lymphoproliferative disorder AC Roden, WR Macon, GL Keeney, JL Myers, AL Feldman, A Dogan Modern Pathology 21 (4), 455-463, 2008 | 203 | 2008 |
| Specificity of IRF4 translocations for primary cutaneous anaplastic large cell lymphoma: a multicenter study of 204 skin biopsies DA Wada, ME Law, ED Hsi, DJ DiCaudo, L Ma, MS Lim, A Souza, ... Modern Pathology 24 (4), 596-605, 2011 | 196 | 2011 |
